Citations

Showing 10 of 108104 citations.

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy
Rocca, Walter A. , Geda, Yonas E. , Gostout, Bobbie S., Bower, James H., Maraganore, Demetrius M. , Melton, L. Joseph , Geda, Yonas E , Grossardt, Brandon R. , Andrade, Mariza de

Mayo Clinic

Menopause | October 25, 2018 | Volume: 25 | Issue: 11 | Pages: 1275-1285

10.1097/gme.0000000000001229 | PMID 30358723 Get It

Abstract Objective: We studied the long-term risk of depressive and anxiety symptoms in women who underwent bilateral oophorectomy before menopause. Design: We conducted a cohort study among all women residing in Olmsted County, MN, who underwent bilateral oophorectomy before the onset of menopause for a noncancer indication from 1950 through 1987. Each member of the bilateral oophorectomy cohort was matched by age with a referent woman from the same population who had not undergone an oophorectomy. In total, we studied 666 women with bilateral oophorectomy and 673 referent women. Women were followed for a median of 24 years, and depressive and anxiety symptoms were assessed using a structured questionnaire via a direct or proxy telephone interview performed from 2001 through 2006. Results: Women who underwent bilateral oophorectomy before the onset of menopause had an increased risk of depressive symptoms diagnosed by a physician (hazard ratio = 1.54, 95% CI: 1.04-2.26, adjusted for age, education, and type of interview) and of anxiety symptoms (adjusted hazard ratio = 2.29, 95% CI: 1.33-3.95) compared with referent women. The findings remained consistent after excluding depressive or anxiety symptoms that first occurred within 10 years after oophorectomy. The associations were greater with younger age at oophorectomy but did not vary across indications for the oophorectomy. In addition, treatment with estrogen to age 50 years in women who underwent bilateral oophorectomy at younger ages did not modify the risk. Conclusions: Bilateral oophorectomy performed before the onset of menopause is associated with an increased long-term risk of depressive and anxiety symptoms.
Risk of fall in patients taking proton pump inhibitors: a meta-analysis
Lapumnuaypol, Kamolyut , Wijarnpreecha, Karn , Tiu, Andrew , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Wijarnpreecha, Karn , Thongprayoon, Charat

Mayo Clinic

QJM: An International Journal of Medicine | October 25, 2018 | Volume: 112 | Issue: 2 | Pages: 115-121

10.1093/qjmed/hcy245 | PMID 30364990 Get It

Age-related DNA methylation and hemostatic factors
Andrade, Mariza de , de Andrade, Mariza

Mayo Clinic

Blood | October 25, 2018 | Volume: 132 | Issue: 17 | Pages: 1736-1736

10.1182/blood-2018-08-867028 | PMID 30361463 Get It

Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency
Bianchi, Paola , Fermo, Elisa , Glader, Bertil , Kanno, Hitoshi , Agarwal, Archana M. , Barcellini, Wilma , Eber, Stefan , Hoyer, James D., Kuter, David J. , Maia, Tabita , Mañú‐Pereira, María del Mar, Kalfa, Theodosia A. , Pissard, Serge , Segovia, José C. , Beers, Eduard J. van , Gallagher, Patrick G. , Rees, David C. , Wijk, Richard van , Diseases, with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological, Agarwal, Archana , van Beers, Eduard , Kuter, David J. , Diseases, with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological

Mayo Clinic

American Journal of Hematology | October 25, 2018 | Volume: 94 | Issue: 1 | Pages: 149-161

10.1002/ajh.25325 | PMID 30358897 Get It

Abstract Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.
A Retrospective Multicenter Evaluation of Clozapine Use in Pediatric Patients Admitted for Acute Psychiatric Hospitalization
Steinauer, Laura M., Leung, Jonathan G. , Burkey, Betsy Walters, McGrane, Ian R. , Letts, Victoria, Gören, Jessica L. , Hoeft, Dawn, Mullen, Sandra, Schak, Kathryn M. , Voort, Jennifer L. Vande , Vande Voort, Jennifer L., Leung, Jonathan G , McGrane, Ian , Maroney, Megan E.

Mayo Clinic

Journal of Child and Adolescent Psychopharmacology | October 25, 2018 | Volume: 28 | Issue: 9 | Pages: 615-619

10.1089/cap.2018.0036 | PMID 30358422 Get It

Work of breathing influences muscle sympathetic nerve activity during semi‐recumbent cycle exercise
Dominelli, Paolo B. , Katayama, Keisho , Vermeulen, Tyler D. , Stuckless, Troy J.R. , Brown, Courtney V. , Foster, Glen E. , Sheel, A. William , Foster, Glen E

Mayo Clinic

Acta Physiologica | October 25, 2018 | Volume: 225 | Issue: 4 | Pages: No page available

10.1111/apha.13212 | PMID 30358142 Get It

AbstractReducing the work of breathing during exercise improves locomotor muscle blood flow and reduces diaphragm and locomotor muscle fatigue and is thought to be the result of a sympathetically mediated reflex.AimThe aim of this study was to assess muscle sympathetic nerve activity (MSNA) when the work of breathing is experimentally lowered during dynamic exercise.MethodsHealthy subjects (n = 12; age = 29 ± 9 years) performed semi‐recumbent cycling trials at 40%, 60%, and 80% of peak workload. Exercise trials consisted of spontaneous breathing, reduced work of breathing (proportional assist ventilator), followed by further spontaneous breathing (post‐ventilator). MSNA was recorded from the median nerve.ResultsThere was no difference in work of breathing between PAV and post‐PAV at 40% peak work. At 60% peak work, the ventilator significantly (P < 0.05) reduced work of breathing (103 ± 39 vs 144 ± 47 J min−1), sympathetic nerve activity (35 ± 5 vs 42 ± 8 burst min−1), and (2.4 ± 0.5 vs 2.6 ± 0.5 L min−1) without influencing ventilation (86 ± 9 vs 82 ± 10 L min−1; P > 0.05), for PAV and post‐PAV respectively. During 80% peak work (n = 8), the ventilator significantly (P < 0.05) reduced work of breathing (235 ± 110 vs. 361 ± 150 J min−1), MSNA (48 ± 7 vs 54 ± 11 burst min−1), and (2.9 ± 0.6 vs 3.2 ± 0.7 L min−1) but not ventilation (121 ± 20 vs 123 ± 20 L min−1; P > 0.05), for PAV and post‐PAV respectively. There was a significant relationship between MSNA and (P < 0.0001) with a significant interaction due to the ventilator (P < 0.05).ConclusionLowering the normally occurring work of breathing during exercise results in commensurate reductions in MSNA. Our findings provide evidence of a sympathetically mediated vasoconstrictor effect emanating from respiratory muscles during exercise.
Diagnostic and therapeutic value of implantable loop recorder: A tertiary care center experience
Padmanabhan, Deepak , Kancharla, Krishna , El‐Harasis, Majd , Isath, Ameesh , Makkar, Nayani , Noseworthy, Peter A. , Friedman, Paul A. , Cha, Yong‐Mei , El-Harasis, Majd A, Kapa, Suraj , Noseworthy, Peter A , Kapa, Suraj

Mayo Clinic

Pacing and Clinical Electrophysiology | October 25, 2018 | Volume: 42 | Issue: 1 | Pages: 38-45

10.1111/pace.13533 | PMID 30357866 Get It

AbstractBackgroundImplantable loop recorders (ILRs) are effective in achieving symptom‐rhythm correlation. However, diagnostic yield in routine clinical practice is not well established.MethodsPatients undergoing ILR implantation between April 2010 and May 2015 were included. All devices were enrolled in remote monitoring with automatic arrhythmia detection and P sense algorithms switched “ON.” Symptom‐rhythm correlation was assessed and changes in management were recorded.ResultsA total of 312 patients (57% male, age 53 ± 22 years; median CHADS2VaSc score = 1) were included in this study. ILRs were implanted for evaluation of syncope in 206 (66.0%), presyncope in 23 (7.4%), unexplained palpitations in 51 (16.3%), and cryptogenic stroke in 27 (8.7%) patients. ILR monitoring yielded a diagnosis that changed management strategy in 146 (46.8%) patients over a median of 12 (1‐42) months. Out of 163 (52.2%) patients with symptoms during the monitoring period, 100 (61.3%) had an arrhythmia. ILR was useful in ruling out an arrhythmic cause for symptoms in 63 (38.7%) patients. ILR results led to pacemaker implantation in 23 patients (7.4% overall and 11.2% of those with syncope) after median follow‐up of 3 months. A new diagnosis of atrial fibrillation was made in 38 (12.2%) patients, 11 of whom were initiated on oral anticoagulants. ILR results led to pacemaker implantation in 31 patients (9.9% overall and 19.0% of those with syncope) after median follow‐up of 3 months. A new diagnosis of atrial fibrillation was made in 38 (12.2%) patients, nine of whom were initiated on oral anticoagulants. Overall, ILR led to a change in management in 47% patients with a number needed to implant of 2.1 to change management.ConclusionILR monitoring is effective in achieving symptom‐rhythm correlation and results in changes in management in nearly half of implanted patients. Additional studies are needed to evaluate cost efficacy of ILR and the optimal monitoring duration.
Fast Cyclic Square-Wave Voltammetry To Enhance Neurotransmitter Selectivity and Sensitivity
Park, Cheonho , Shin, Hojin , Kim, Jaekyung , Kang, Yumin , Sim, Jeongeun, Cho, Hyun U., Lee, Han Kyu , Jung, Sung Jun , Bennet, Kevin E. , Heien, Michael L. , Lee, Kendall H. , Kim, In Young , Jang, Dong Pyo , Heien, Michael L , Jang, Dong Pyo , Oh, Yoonbae , Blaha, Charles D.

Mayo Clinic

Analytical Chemistry | October 25, 2018 | Volume: 90 | Issue: 22 | Pages: 13348-13355

10.1021/acs.analchem.8b02920 | PMID 30358389 Get It

Abstract Although fast-scan cyclic voltammetry (FSCV) has been widely used for in vivo neurochemical detection, the sensitivity and selectivity of the technique can be further improved. In this study, we develop fast cyclic square-wave voltammetry (FCSWV) as a novel voltammetric technique that combines large-amplitude cyclic square-wave voltammetry (CSWV) with background subtraction. A large-amplitude, square-shaped potential was applied to induce cycling through multiple redox reactions within a square pulse to increase sensitivity and selectivity when combined with a two-dimensional voltammogram. As a result, FCSWV was significantly more sensitive than FSCV (n = 5 electrodes, two-way ANOVA, p = 0.0002). In addition, FCSWV could differentiate dopamine from other catecholamines (e.g., epinephrine and norepinephrine) and serotonin better than conventional FSCV. With the confirmation that FCSWV did not influence local neuronal activity, despite the large amplitude of the square waveform, it could monitor electrically induced phasic changes in dopamine release in rat striatum before and after injecting nomifensine, a dopamine reuptake inhibitor.
Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
Liao, Lili, Langbein, Lauren , Cho, Eun-Ah , Niu, Xiaohua , Jiang, Wei , Zhong, Zhijiu , Cai, Wesley L. , Jagannathan, Geetha , Dulaimi, Essel, Testa, Joseph R. , Uzzo, Robert G. , Wang, Yuxin , Stark, George R. , Peiper, Stephen C., Yan, Qin , Yang, Haifeng , Langbein, Lauren , Na, Jie , Xu, Yaomin , Yan, Qin , Yang, Haifeng , Liu, Zongzhi Z. , Cai, Weijia , Na, Jie, Sun, Jianxin

Mayo Clinic

eLife | October 25, 2018 | Volume: 7 | Issue: No issue available | Pages: No page available

10.7554/elife.37925 | PMID 30355451 Get It

Whereas VHL inactivation is a primary event in clear cell renal cell carcinoma (ccRCC), the precise mechanism(s) of how this interacts with the secondary mutations in tumor suppressor genes, including PBRM1 , KDM5C / JARID1C , SETD2 , and/or BAP1 , remains unclear. Gene expression analyses reveal that VHL, PBRM1, or KDM5C share a common regulation of interferon response expression signature. Loss of HIF2α, PBRM1, or KDM5C in VHL-/- cells reduces the expression of interferon stimulated gene factor 3 (ISGF3), a transcription factor that regulates the interferon signature. Moreover, loss of SETD2 or BAP1 also reduces the ISGF3 level. Finally, ISGF3 is strongly tumor-suppressive in a xenograft model as its loss significantly enhances tumor growth. Conversely, reactivation of ISGF3 retards tumor growth by PBRM1-deficient ccRCC cells. Thus after VHL inactivation, HIF induces ISGF3, which is reversed by the loss of secondary tumor suppressors, suggesting that this is a key negative feedback loop in ccRCC.
GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist
Chakraborty, Subhankar , Halland, Magnus , Burton, Duane D. , Desai, Anshuman, Neja, Bridget, Low, Phillip A. , Camilleri, Michael , Zinsmeister, Alan R., Bharucha, Adil E. , Chakraborty, Subhankar , Burton, Duane, Singer, Wolfgang

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 25, 2018 | Volume: 104 | Issue: 6 | Pages: 1967-1977

10.1210/jc.2018-01623 | PMID 30358871 Get It